Adequate bone marrow, cardiac, kidney and liver function
Patients with renal abnormalities, such as pelvic kidney, horseshoe kidney, or renal transplantation, that would require modification of radiation fields
Adequate bone marrow, kidney, and liver function
Prior SOT of kidney, liver, heart, lung, pancreas, small bowel, or any combination of these
Adequate bone marrow, kidney and liver function
Adequate bone marrow, kidney and liver function
Adequate bone marrow, liver and kidney function
Participants have adequate bone marrow, kidney and liver function.
Adequate bone marrow, kidney and liver function
Good kidney and liver function
Adequate bone marrow, cardiac, kidney and liver function
Severe impairment of your kidney or liver function
Patients must have adequate bone marrow, kidney, and liver function, (within  days prior to registration), defined as:
Must have adequate coagulation, hematology, kidney, and liver function, per protocol.
Patient with bilateral LG UTUC may be enrolled if at least one side meets the inclusion criteria for the trial and if the other kidney does not require further treatments (The other kidney can be treated prior to the beginning of the study).
Good kidney and liver function
Normal liver, kidney and bone marrow function
Patients with renal abnormalities, such as pelvic kidney, horseshoe kidney, or renal transplantation, that would require modification of surgical lymph node assessments
Must have adequate hepatic and kidney function.
Adequate bone marrow, liver and kidney function
Kidney function: creatinine < . x ULN.
History of severe kidney disease (e.g chronic or acute kidney failure) with creatinine clearance below  and/or severe liver disease with liver tests over  times the upper normal level
Patient with only  kidney
History of kidney stones
In cases of concern about decreased renal function and potential high radiation dose to the kidneys, an optional nuclear medicine kidney function scan may be performed prior to radiation therapy to determine the functional contribution of each kidney
Significant liver, lung, heart, or kidney dysfunction
Cases in which the subject has a solitary or horseshoe kidney
Cases in which the subject has more than two masses in the applicable kidney
Chronic kidney disease > stage .
Adequate bone marrow, liver, kidney function
Adequate bone marrow, kidney, and hepatic function (no laboratory value >  times the normal limit)
Patients with renal abnormalities, such as pelvic kidney, horseshoe kidney, or renal transplantation, that would require modification of radiation fields
Adequate bone marrow, kidney and liver function
Patients must have adequate heart, kidney, liver and bone marrow function.
Subject must have adequate kidney and liver function as described in the protocol
Abnormal kidney function test results
Adequate hematologic, liver, coagulation and kidney function
Adequate bone marrow, kidney and liver function
Adequate liver, kidney, and bone marrow function
Adequate bone marrow, kidney and liver function.
Performance Status of  or  - Adequate bone marrow, kidney and liver function
Active severe kidney or liver disease
Patients with renal abnormalities, such as pelvic kidney, horseshoe kidney, or renal transplantation, that would require modification of surgical lymph node assessments
Adequate organ function (bone marrow, kidney and liver)
Adequate kidney function
Adequate liver, kidney, and bone marrow function
Participants must have adequate liver, kidney, and bone morrow function
Adequate glucose control, bone marrow, kidney, liver, and heart function.
Creatinine =<  x upper limit of normal, unless there is known chronic kidney disease (CKD) (creatinine must be at baseline for subjects with chronic kidney disease)
Patients with a solitary kidney
Adequate bone marrow, kidney and liver function
Severe impairment of your kidney or liver function
Adequate bone marrow, kidney, liver, and heart function.
Adequate blood, liver, and kidney function as defined by laboratory tests.
Subjects must have adequate kidney function
Adequate hematologic, kidney and liver function
Adequate bone morrow and kidney function
Adequate bone marrow, kidney and liver function
Acceptable bone marrow, liver and kidney function.
Adequate bone marrow, kidney, and liver function
Has adequate organ function (bone marrow, kidney and liver)
Kidney: albuminuria ?  mg/day in a -hour urine specimen
Have adequate cardiac, bone marrow, liver and kidney function
Participants must have adequate hepatic and kidney function.
Patients must have acceptable neutrophil and platelet counts as well as adequate kidney and liver function.
Patients with recent history of kidney stones.
Kidney tumor has been removed
Adequate hematologic and organ function, including blood counts, liver and kidney function Stage I Arm A (GDC-):
Normal kidney and liver function (lab results must be within  days prior enrollment)
Significant kidney disease that would inhibit administration of gabapentin
Solitary kidney
No active kidney stones
Chronic kidney disease or in participants without known kidney disease, estimated creatinine clearance of =<  ml/min, even after rehydration
Patient has a single functioning kidney
Any history of cardiovascular, kidney, or liver disease
acute kidney injury
Adequate bone marrow, liver and kidney function
History of known nephrolithiasis (kidney stones)
History of severe kidney disease (e.g. chronic or acute kidney failure) with creatinine clearance below  and/or severe liver disease with liver tests over  times the upper normal level
Single solid organ recipient (kidney only)
Underlying kidney disease with a high risk of disease recurrence in the transplanted kidney
Known chronic kidney disease (creatinine >= .)
Adequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:
Have adequate bone marrow reserves and liver and kidney function, as assessed by the following laboratory requirements:
History of known nephrolithiasis (kidney stones)
Patients with a history of renal lithiasis within the last  years or patients with evidence of kidney stones on entry evaluation
Have kidney disease, defined as either CKD II-V, determined by estimated glomerular filtration rate (GFR) of <  and derived from serum creatinine measurements, or albuminuria/proteinuria, determined by albumin to creatinine ratio or protein to creatinine ratio of >  mg/gm within  months of recruitment, or on dialysis or having received a kidney transplant or have biopsy proven kidney disease
Medical condition\r\n* Renal transplant\r\n* Active or ongoing kidney disease or kidney failure, including but not limited to: functioning renal transplant, solitary kidney, proteinuria, multiple myeloma, acute and chronic nephropathies\r\n* Myasthenia gravis\r\n* Thyroid cancer or overactive thyroid\r\n* Severe congestive heart failure
Patients who have chronic kidney disease
Renal (kidney) disease, or solitary kidney
No evidence of impaired hepatic or kidney function
or have a history of kidney disease.
The protocol nurse will check with the patient that there is no history of (h/o) kidney disease
Good kidney and liver function
Adequate bone marrow, liver, and kidney function within  weeks prior to first dose
Adequate function of kidney:
Adequate bone marrow, kidney and liver function
